Literature DB >> 34908712

Impact of COVID-19 pandemic on persons with psychiatric disorders.

A V Sowmya1, Archana Javadekar1, Preethi Menon1, Daniel Saldanha1.   

Abstract

From the beginning of COVID-19 pandemic, concerns have been raised about its effect on mental health and on patients with psychiatric illnesses. A few reports suggest that patients with COVID-19 have increased symptoms of anxiety disorders, post-traumatic stress disorder, depression, increased substance use, and insomnia. There is an increased trend seen in flare-up of psychotic symptoms and new emergence of psychotic symptoms in previously healthy adults. There is extensive research available on the impact of COVID-19 on physical health, but there is a paucity of studies on the effects of COVID-19 on psychiatric illness. Copyright:
© 2021 Industrial Psychiatry Journal.

Entities:  

Keywords:  Anxiety; COVID-19; depression; psychosis; substance use disorders

Year:  2021        PMID: 34908712      PMCID: PMC8611553          DOI: 10.4103/0972-6748.328832

Source DB:  PubMed          Journal:  Ind Psychiatry J        ISSN: 0972-6748


  11 in total

1.  Survey of stress reactions among health care workers involved with the SARS outbreak.

Authors:  YaMei Bai; Chao-Cheng Lin; Chih-Yuan Lin; Jen-Yeu Chen; Ching-Mo Chue; Pesus Chou
Journal:  Psychiatr Serv       Date:  2004-09       Impact factor: 3.084

2.  A sense of dread: affect and risk perception in people with schizophrenia during an influenza pandemic.

Authors:  Paul A Maguire; Rebecca E Reay; Jeffrey Cl Looi
Journal:  Australas Psychiatry       Date:  2019-04-15       Impact factor: 1.369

3.  COVID-19 paranoia in a patient suffering from schizophrenic psychosis - a case report.

Authors:  M Fischer; A N Coogan; F Faltraco; J Thome
Journal:  Psychiatry Res       Date:  2020-04-17       Impact factor: 3.222

4.  The role of stress-reactivity, stress-recovery and risky decision-making in psychosocial stress-induced alcohol consumption in social drinkers.

Authors:  James M Clay; Matthew O Parker
Journal:  Psychopharmacology (Berl)       Date:  2018-09-12       Impact factor: 4.530

5.  Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis.

Authors:  Bolin Wang; Ruobao Li; Zhong Lu; Yan Huang
Journal:  Aging (Albany NY)       Date:  2020-04-08       Impact factor: 5.682

6.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.

Authors:  Fei Zhou; Ting Yu; Ronghui Du; Guohui Fan; Ying Liu; Zhibo Liu; Jie Xiang; Yeming Wang; Bin Song; Xiaoying Gu; Lulu Guan; Yuan Wei; Hui Li; Xudong Wu; Jiuyang Xu; Shengjin Tu; Yi Zhang; Hua Chen; Bin Cao
Journal:  Lancet       Date:  2020-03-11       Impact factor: 79.321

7.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

Review 8.  The psychological impact of quarantine and how to reduce it: rapid review of the evidence.

Authors:  Samantha K Brooks; Rebecca K Webster; Louise E Smith; Lisa Woodland; Simon Wessely; Neil Greenberg; Gideon James Rubin
Journal:  Lancet       Date:  2020-02-26       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.